Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK
Clinical trial NCT01960374 · COMPLETED
Trial details
- NCT number
- NCT01960374
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-05-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.